Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesTemporary CodesHCPCS hcpcs-q4188-amnioarmor-amniotic-membrane-graft-per-sq-cm
    Ask Trek AI about this page

    HCPCS Level II Q4188: AmnioArmor per Square Centimeter (Add-on)

    Medicare pays $133 on average nationally for this procedure.

    HCPCS Level II code Q4188 describes billing for AmnioArmor tissue product charged per square centimeter as an add-on item to be listed separately in addition to a primary surgical or wound-care procedure; the service represents provision of an amniotic membrane-derived biologic graft and is typically used in surgical wound coverage or soft-tissue repair settings, billed in operative or procedural sites such as ambulatory surgery centers, hospital operating rooms, or specialized wound care clinics.

    For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.

    Customize your policy alerts

    Sign up for hcpcs Q4188 policy alerts

    Get alerted when payer policies referencing Q4188 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A typical patient is an adult presenting with a complex, non-healing surgical wound or full-thickness soft tissue defect after debridement or excision (for example, chronic diabetic foot ulcer, non-healing venous stasis ulcer, or a post-traumatic soft tissue defect). The treating clinician (commonly a wound care surgeon, plastic surgeon, or podiatrist) performs operative wound bed preparation, including debridement and hemostasis, followed by application of an amniotic membrane product billed as Q4188 measured and reported per square centimeter as an add-on supply item.

    Workflow steps:

    • Pre-procedure evaluation by the surgeon or wound care specialist with documentation of wound size, depth, vascular status, infection status, and prior treatments.

    • Operating room or procedure suite preparation with appropriate anesthesia (local, regional, or monitored sedation) and sterile field.

    • Sharp surgical debridement and hemostasis; irrigation and assessment of wound base and adjacent tissue.

    • Application of Amnioarmor product cut to size; quantification in square centimeters documented in the operative note and supply records for billing Q4188 as an add-on to the primary procedure.

    • Securement of the graft/membrane and dressing application; post-procedure wound care instructions and follow-up arranged for graft take assessment and dressing changes.

    • Documentation must tie the use of Q4188 to the primary surgical or wound procedure code, include the exact square-centimeter amount used, and note clinical rationale (e.g., to promote re-epithelialization and modulate inflammation).

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    11042Debridement, muscle and/or fascia (first 20 sq cm or less)Commonly performed prior to application of an amniotic membrane to prepare the wound bed.
    15271Placement of biologic or synthetic skin substitute graft (first 50 sq cm)CPT for placement of skin substitutes; Q4188 is billed as an add-on supply for an amniotic product used in conjunction.
    97602Debridement (e.g., wound cleansing, selective debridement without anesthetic)Non-surgical debridement code used in clinic before definitive operative application of biologic grafts.
    15999Unlisted skin and subcutaneous tissue procedureUsed when a skin substitute placement does not map to a specific CPT; may be reported alongside when applicable.

    Related Modifiers

    5 rows

    ModifierDescriptionWhen to Use
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207X00000X
    208000000X
    367500000X
    363A00000X
    207SG0207X
    207QD0401X
    246R00000X
    224ZR0403X

    Related ICD-10-CM Codes

    17 rows

    ICD-10-CM CodeDescription
    H02.831Dermatochalasis of right upper eyelid
    H02.832Dermatochalasis of right lower eyelid
    H02.833Dermatochalasis of right eye, unspecified eyelid
    H04.121Dry eye syndrome of right lacrimal gland
    H04.122Dry eye syndrome of left lacrimal gland
    H10.9Unspecified conjunctivitis
    H11.32Conjunctival hemorrhage, left eye
    H16.211Exposure keratoconjunctivitis, right eye
    H16.221Keratoconjunctivitis sicca, not specified as Sjogren's, right eye
    H16.9Unspecified keratitis

    Showing 1–10 of 17

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    HIV/AIDS Pharmacologic Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Testing for Diagnosis of Active or Latent TuberculosisOscar Health2026-10-01

    Related Codes

    HCPCS-LEVEL-II-Q4139-INJECTABLE-AMNIOMATRIX-BIODMATRIX-1-CC

    HCPCS Q4139: Amniomatrix or Biodmatrix, Injectable, 1 cc

    HCPCS-LEVEL-II-Q4256-AREA-BASED-PROCEDURAL-ADD-ON-PER-SQ-CM

    HCPCS Q4256: MLG-complete Skin Graft Material, Per Sq Cm

    HCPCS-LEVEL-II-Q5132-ADALIMUMAB-AFZB-ABRILADA-10MG-INJECTION

    HCPCS Level II Q5132: Injection, adalimumab-afzb (Abrilada), 10 mg

    HCPCS-Q0035-CARDIOKYMOGRAPHY-CARDIAC-MOTION-RECORDING

    HCPCS Level II Q0035: Cardiokymography

    HCPCS-Q0081-INFUSION-THERAPY-NON-CHEMOTHERAPEUTIC-PER-VISIT

    HCPCS Level II Q0081: Infusion Therapy, Non‑Chemotherapeutic, Per Visit

    HCPCS-Q0083-CHEMOTHERAPY-NON-INFUSION-ADMINISTRATION

    HCPCS Q0083: Chemotherapy Administration, Non-Infusion Methods

    HCPCS-Q0084-CHEMOTHERAPY-INFUSION-ADMINISTRATION-PER-VISIT

    HCPCS Q0084: Chemotherapy Infusion Administration, Per Visit

    HCPCS-Q0085-CHEMOTHERAPY-INFUSION-PLUS-OTHER-TECHNIQUES-PER-VISIT

    HCPCS Q0085: Chemotherapy Infusion Plus Other Technique(s), Per Visit

    HCPCS-Q0091-PAP-SMEAR-SPECIMEN-COLLECTION-TRANSPORT

    HCPCS Q0091: Screening Papanicolaou Smear Collection and Transport

    HCPCS-Q0092-PORTABLE-XRAY-EQUIPMENT-SETUP

    HCPCS Q0092: Set-up Portable X-ray Equipment

    Showing 1–10 of 629

    • More pages

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Q4188
    15275Application of skin substitute to trunk, arms, legs; first 100 sq cmUsed for larger graft placements where amniotic membrane is part of the reconstructive strategy.